Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
Holders of 5% or more of EVOK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evoke Pharma Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Klein Roger M. | 13D | 10.50%163.0K shares | New | Nov 12, 20251 filing | Nov 12, 2025 | SEC |
| Bleichroeder LP | 13G/A | 9.99%158.1K shares | 0.00 ppfrom 9.99% | Mar 21, 20252 filings | Mar 24, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Evoke Pharma Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 20254:15 PM ET | Nantahala Capital Management, LLCand 2 others | 13D/A | 0.00%0 shares | −15.99 ppfrom 15.99%Below 5% | Dec 17, 2025 | SEC |
| Dec 5, 20254:03 PM ET | Morgan Stanleyand 1 other | 13G/A | 0.00%31 shares | −10.50 ppfrom 10.50%Below 5% | Nov 30, 2025 | SEC |
| Nov 12, 20254:41 PM ET | Klein Roger M.and 1 other | 13D | 10.50%163.0K shares | New | Nov 4, 2025 | SEC |
| Nov 4, 202511:40 AM ET | Nantahala Capital Management, LLCand 2 others | 13D/A | 15.99%268.4K shares | 0.00 ppfrom 15.99% | Nov 3, 2025 | SEC |
| Sep 8, 20254:33 PM ET | Morgan Stanleyand 1 other | 13G | 10.50%163.7K shares | New | Aug 31, 2025 | SEC |
| May 15, 20253:51 PM ET | Lytton Laurence W | 13G/A | 3.90%61.3K shares | –Below 5% | Mar 31, 2025 | SEC |
| Mar 24, 20256:47 PM ET | Bleichroeder LPand 2 others | 13G/A | 9.99%158.1K shares | 0.00 ppfrom 9.99% | Mar 24, 2025 | SEC |
| Mar 21, 20257:15 PM ET | Bleichroeder LPand 2 others | 13G/A | 9.99%849.4K shares | – | Mar 19, 2025 | SEC |
| Feb 3, 20254:47 PM ET | Nantahala Capital Management, LLCand 2 others | 13D/A | 15.99%254.6K shares | – | Feb 3, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Evoke Pharma Inc shares.
No Form 144 notices for Evoke Pharma Inc are on file.